APA (7th ed.) Citation

Jean-Christophe Wyss, Rajesh Kumar, Josip Mikulic, Manfred Schneider, Jean-Luc Mary, Johannes D. Aebi, . . . Dela Golshayan. (2019). Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Jean-Christophe Wyss, Rajesh Kumar, Josip Mikulic, Manfred Schneider, Jean-Luc Mary, Johannes D. Aebi, Lucienne Juillerat-Jeanneret, Lucienne Juillerat-Jeanneret, and Dela Golshayan. Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury. Frontiers Media S.A., 2019.

MLA (9th ed.) Citation

Jean-Christophe Wyss, et al. Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury. Frontiers Media S.A., 2019.